MadeMed review

There is no month-to-month plan at MadeMed. A quarter is the shortest term sold on any of the four products, so the smallest charge for injectable semaglutide is $717 — quoted as $239 a month, billed all at once. Each product carries two rungs. Injectable semaglutide is $239 a month on the quarterly plan ($717 per charge) or $199 on the six-month plan ($1,194 per charge). Sublingual semaglutide is $219 quarterly ($657) or $179 for six months ($1,074). Injectable tirzepatide is $399 quarterly ($1,197) or $369 for six months. Sublingual tirzepatide is $299 quarterly ($897) or $279 for six months.

Every product page leads with the six-month number — "From $199/mo", "From $179/mo", "From $369/mo", "From $279/mo" — so the price quoted anywhere else is the one that requires committing to half a year and paying for it in one charge. The quarterly rung is the one most people will actually reach, and it runs $20 to $40 a month higher on every product.

The needle-free route is the cheaper one on both molecules, which is not how this usually goes. Sublingual semaglutide undercuts the injection by $20 a month at either term, and sublingual tirzepatide undercuts injectable tirzepatide by $100 a month quarterly and $90 on the six-month plan. The cheapest thing MadeMed sells is sublingual semaglutide at $179 a month on the six-month plan; the largest single charge is $1,197 for a quarter of injectable tirzepatide. Both molecules are sold in both routes, so the choice between a needle and a tablet is not also a choice of drug.

Within a plan the price does not move with the dose. Injectable semaglutide is $239 a month at 0.25 mg and still $239 at 2.4 mg; injectable tirzepatide is $399 from 2.5 mg through 15 mg; sublingual tirzepatide is $299 from 3 mg through 7 mg. That is a genuine advantage if you intend to titrate up to a full dose, because the entire schedule can be costed before you start. It is a genuine disadvantage if you plan to sit at a starting dose or microdose, because you pay the full-dose rate the whole time.

The price is quoted per month; the shipment is not. A vial ships every two months, and the sublingual tablets arrive as 60 tablets covering two months. That changes nothing about the cost, but it does change what lands on your doorstep and when — a $717 quarterly charge buys deliveries on a two-month rhythm, not three monthly boxes.

If a prescription does not come through, the refund is not complete: MadeMed keeps a $39 doctor visit fee. It is a small amount against a $717 charge, but it is a real cost of finding out whether you qualify, and it is the kind of line that usually only appears at checkout.

The state footprint depends on which product you want, and the gap is wide. Oral tirzepatide is offered in 40 states. Injectable semaglutide names 23: Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Maine, Missouri, Montana, North Dakota, New Mexico, New York, Rhode Island, South Dakota, Texas, Utah, Vermont, Wisconsin and Wyoming. If you want the injection and your state is not on that list, the 40-state figure is not the one that applies to you.

Everything sold here is compounded, with no brand-name pathway on any of the four products, with physician review on a LegitScript-verified platform. It suits someone who has already settled on a molecule and a route, wants the exact cost of a full titration before starting, and can put $657 to $1,197 on a card in one go. It suits nobody who wants to try a single month, because a single month is not for sale.